They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

Much of the excitement, for both type 1 and type 2 diabetes, is about disease modification and claims of drugs being disease modifying. But what does disease modifying mean? Other drugs require ...

Researchers today are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes. Because the study ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Credit: Getty Images Experts weigh in on the ramifications of GLP-1 drug shortages and how they affect patients who need ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...

Attorney General Phil Weiser announced the $10 million settlement with Heritage Pharmaceuticals and $39.1 million settlement ...

The third-quarter earnings season was at its peak this week for large drugmakers, with several companies — Eli Lilly LLY, ...